Vascular Stents

Vascular Stents

Global Vascular Stents Market to Reach US$13.3 Billion by 2030

The global market for Vascular Stents estimated at US$10.0 Billion in the year 2023, is expected to reach US$13.3 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Balloon-Expandable Stents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$9.2 Billion by the end of the analysis period. Growth in the Self-Expandable Stents segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 7.8% CAGR

The Vascular Stents market in the U.S. is estimated at US$2.7 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.0 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Vascular Stents Market - Key Trends & Drivers Summarized

Why Are Vascular Stents Crucial in Treating Vascular Diseases?

Vascular stents have become a cornerstone in the treatment of various vascular diseases, including coronary artery disease, peripheral artery disease, and aneurysms. These devices are used to open narrowed or blocked blood vessels, restoring proper blood flow and preventing complications such as heart attacks or strokes. The rising incidence of vascular diseases, driven by factors such as aging populations, sedentary lifestyles, and increasing rates of obesity and diabetes, has led to a growing demand for vascular stents. As medical practitioners seek to improve patient outcomes and reduce the risk of recurrent blockages, the adoption of advanced stent technologies has accelerated, driving the market forward.

How Are Technological Innovations Impacting the Vascular Stents Market?

Technological innovations have significantly impacted the vascular stents market, leading to the development of more effective, safe, and durable devices. The introduction of drug-eluting stents (DES), which release medication to prevent restenosis, has revolutionized the field, reducing the need for repeat procedures and improving long-term patient outcomes. Additionally, the development of bioresorbable stents, which gradually dissolve after fulfilling their function, represents a major advancement in reducing long-term complications associated with permanent implants. The use of advanced materials, such as cobalt-chromium and platinum-chromium alloys, has also improved the flexibility, strength, and radiopacity of stents, allowing for more precise placement and better performance in complex anatomies. These technological advancements are driving the widespread adoption of vascular stents, as they offer significant benefits in the treatment of vascular diseases.

What Are the Emerging Trends in Vascular Stents?

The vascular stents market is witnessing several emerging trends that are shaping its future. One key trend is the growing preference for minimally invasive procedures, which are driving the demand for stents that can be delivered through smaller incisions with greater precision. The rise in the use of drug-coated balloons (DCBs) in combination with stents is another trend, offering a complementary approach to reducing restenosis and improving patient outcomes. The market is also seeing an increased focus on the development of stents for specific patient populations, such as those with diabetes or complex vascular anatomies, leading to more personalized treatment options. Additionally, the growing interest in hybrid stents, which combine the benefits of both bare-metal and drug-eluting stents, is influencing the market`s evolution, as these devices offer a balance between long-term safety and efficacy.

What Factors Are Driving the Growth of the Vascular Stents Market?

The growth in the vascular stents market is driven by several factors, including the increasing prevalence of vascular diseases, which are major contributors to global morbidity and mortality. The rising demand for minimally invasive procedures, driven by the need to reduce patient recovery times, hospital stays, and healthcare costs, is also fueling market growth. Additionally, the continuous advancements in stent technology, including the development of drug-eluting, bioresorbable, and hybrid stents, are expanding the range of treatment options available to healthcare providers. The growing focus on personalized medicine, which emphasizes the importance of tailoring treatments to individual patient needs, is further boosting the adoption of advanced stents. Moreover, the increasing availability of vascular stents in emerging markets, supported by improving healthcare infrastructure and rising awareness of cardiovascular health, is contributing to the market`s expansion.

Select Competitors (Total 26 Featured) -

• Abbott Laboratories, Inc.
• B. Braun Melsungen AG
• BARD, A Becton, Dickinson Company
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Endologix, Inc.
• Jotec GmbH
• Lombard Medical Technologies, Inc.
• Medtronic PLC
• Meril Life Sciences Pvt., Ltd.
• MicroPort Scientific Corporation
• Terumo Corporation
• Translumina GmbH
• Vascular Concepts Ltd.
• W.L. Gore & Associates, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.